We've found
184,457
clinical trials
Pregnancy Clinical Trial
Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved Reliability
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
Vitiligo Vulgaris Clinical Trial
Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
Status: Enrolling
Updated: 12/29/2015
Click here to add this to my saved trials
Musculoskeletal, Other Clinical Trial
Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Due to Burn Injury
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
I
Updated: 1/14/2016
Click here to add this to my saved trials
Acute Promyelocytic Leukemia With PML-RARA Clinical Trial
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurofibromatosis Type 1 Clinical Trial
Neurofibromatosis Type 1 Patient Registry
Status: Enrolling
Updated: 12/7/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism
Status: Enrolling
Updated: 8/4/2011
Click here to add this to my saved trials
Neurology Clinical Trial
Exploring Advanced Imaging Techniques to Characterize Botulinum Toxin Diffusion in Human Muscle
Status: Enrolling
Updated: 3/8/2012
Click here to add this to my saved trials
SYSTEMIC SCLERODERMA Clinical Trial
Scleroderma Treatment With Autologous Transplant (STAT) Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
SYSTEMIC SCLERODERMA Clinical Trial
Scleroderma Treatment With Autologous Transplant (STAT) Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
SYSTEMIC SCLERODERMA Clinical Trial
Scleroderma Treatment With Autologous Transplant (STAT) Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
SYSTEMIC SCLERODERMA Clinical Trial
Scleroderma Treatment With Autologous Transplant (STAT) Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
SYSTEMIC SCLERODERMA Clinical Trial
Scleroderma Treatment With Autologous Transplant (STAT) Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
Status: Enrolling,
Phase
IV
Updated: 1/29/2014
Click here to add this to my saved trials
We've found
184,457
clinical trials
Pregnancy Clinical Trial
Updated: 9/16/2013
Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved Reliability
Status: Enrolling
Updated: 9/16/2013
Click here to add this to my saved trials
Vitiligo Vulgaris Clinical Trial
Updated: 12/29/2015
Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
Status: Enrolling
Updated: 12/29/2015
Click here to add this to my saved trials
Musculoskeletal, Other Clinical Trial
Updated: 8/16/2012
Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Due to Burn Injury
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Updated: 2/3/2016
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 2/3/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 1/14/2016
Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
I
Updated: 1/14/2016
Click here to add this to my saved trials
Acute Promyelocytic Leukemia With PML-RARA Clinical Trial
Updated: 12/31/1969
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurofibromatosis Type 1 Clinical Trial
Updated: 12/7/2015
Neurofibromatosis Type 1 Patient Registry
Status: Enrolling
Updated: 12/7/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Updated: 8/4/2011
Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism
Status: Enrolling
Updated: 8/4/2011
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 3/8/2012
Exploring Advanced Imaging Techniques to Characterize Botulinum Toxin Diffusion in Human Muscle
Status: Enrolling
Updated: 3/8/2012
Click here to add this to my saved trials
SYSTEMIC SCLERODERMA Clinical Trial
Updated: 12/31/1969
Scleroderma Treatment With Autologous Transplant (STAT) Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
SYSTEMIC SCLERODERMA Clinical Trial
Updated: 12/31/1969
Scleroderma Treatment With Autologous Transplant (STAT) Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
SYSTEMIC SCLERODERMA Clinical Trial
Updated: 12/31/1969
Scleroderma Treatment With Autologous Transplant (STAT) Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
SYSTEMIC SCLERODERMA Clinical Trial
Updated: 12/31/1969
Scleroderma Treatment With Autologous Transplant (STAT) Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
SYSTEMIC SCLERODERMA Clinical Trial
Updated: 12/31/1969
Scleroderma Treatment With Autologous Transplant (STAT) Study
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/19/2015
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/19/2015
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/19/2015
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/19/2015
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/19/2015
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/19/2015
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/19/2015
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/19/2015
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/19/2015
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/19/2015
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/19/2015
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Status: Enrolling
Updated: 11/19/2015
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 1/29/2014
Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
Status: Enrolling,
Phase
IV
Updated: 1/29/2014
Click here to add this to my saved trials